BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

WuXi XDC and AbTis Sign Memorandum of Understanding for Development and Manufacturing of Antibody Drug Conjugates

Under the partnership, AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing, ADC conjugation process developm...

July 08, 2022 | News

Bumrungrad International Hospital, Southeast Asia's Largest Hospital to Deploy Lunit's AI Cancer Screening System

Lunit and FujiFilm Thailand to supply Lunit INSIGHT CXR and Lunit INSIGHT MMG to one of SEA's largest hospital using Microsoft Azure Aim to detect cance...

July 05, 2022 | News

Seoul National University Hospital selects RayCare to advance oncology system

In April 2022 the carbon ion center at SNUH ordered RayStation treatment planning system, for use with their Toshiba Heavy Ion Therapy System. Th...

July 04, 2022 | News

Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology

“This collaboration with Twist moves us closer to our vision of becoming a fully global healthcare company while also continuing to drive novel thera...

July 01, 2022 | News

Seegene to advance PCR testing

Seegene Inc. (KQ096530), South Korea's leading molecular diagnostics (MDx) company, has obtained EU approval for its Allplex™ SARS-CoV...

June 30, 2022 | News

Seegene develops PCR test to detect monkeypox virus

Assay targets monkeypox virus and can deliver results in 90 minutes Company swiftly rolls out product using its automated assay development system "See...

June 29, 2022 | News

The Peach State Seeks South Korean Life Science Companies to Partake In Its Growing Economy

Over the past five years, Georgia has seen a nearly 30% employment growth in research, testing and medical labs, as well as 16% growth in life sciences and...

June 14, 2022 | News

Standigm Signs MOU with Merck Korea for AI drug Discovery Research

Standigm Inc. ("Standigm"), the leading workflow artificial intelligence (AI) drug discovery company, today announced the signing of a Memorandum of Unders...

June 13, 2022 | News

iNtRON Completes GLP-TOX Studies of BAL200

iNtRON Biotechnology ("iNtRON" or "Company") announced today that the company has successfully completed the GLP toxicology studies of BAL200. The company...

June 07, 2022 | News

New Studies at ASCO 2022 Validate Effectiveness of Lunit AI as Diagnostic Aid in Cancer Treatment

New findings demonstrate the clinical efficacy of AI-powered tissue analysis as a guide in cancer treatment, according to medical AI provider Lunit. The fi...

May 30, 2022 | News

Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic

Includes asymptomatic testing at community-based facilities to prevent widespread transmissions Regular testing for COVID-19, flu, RSV crucial for stayi...

May 26, 2022 | News

Hanmi Fine Chemical Launches 'high-tech CDMO' Business

10 billion KRW invested in Hanmi Fine Chemical facility expansion Hanmi Fine Chemical (hereinafter Hanmi FC) a subsidiary of Hanmi Pharmaceutic...

May 23, 2022 | News

A novel universal antiviral drug introduced in Korea

The birth of a universal antiviral drug with a mechanism applicable to all viral infections is approaching. This antiviral agent, developed ...

May 13, 2022 | News

GenScript ProBio Establishes Korean Legal Entity and Further Strengthens Cooperation in South Korea and APAC Region

During the BIO KOREA 2022, Dr. Brian H. Min, CEO of GenScript ProBio, introduced the development history of GenScript ProBio to the participants and o...

May 13, 2022 | News

Stay Connected